MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Disinhibition"

  • 2019 International Congress

    Ipsilesional arm levitation after left hemispheric stroke: a case series

    M. Klarendic, N. Prezelj, R. Berlot, V. Zgonc, M. Kojovic (Ljubljana, Slovenia)

    Objective: We present three patients with left hemispheric stroke and spontaneous ipsilesional arm levitation (IAL), a phenomenon not hitherto described. Background: Spontaneous arm levitation (AL) is…
  • 2019 International Congress

    Cognitive Inhibitory Control and Response to Dopaminergic Medication in Parkinson’s Disease

    M. El Haddouchi, A. Handberg, K. Svaerke, A. Loekkegaard (Copenhagen, Denmark)

    Objective: To investigate whether response to dopaminergic medication (DM) correlates to inhibitory cognitive control (IC) in patients with Parkinson's disease (PD). Background: In the MDS…
  • 2018 International Congress

    Opposite effects of dopamine on specific NoGo perfomance in young and late onset Parkinson’s disease and the relationship to nigrostriatal degeneration

    D. Kübler, H. Schroll, U. Scheller, R. Buchert, A. Kühn (Berlin, Germany)

    Objective: To investigate inhibitory control under dopamine (DA) in Parkinson’s disease (PD). Background: The pattern of degeneration in PD as well as side effects of…
  • 2017 International Congress

    Global inhibitory control in PD is impaired ON dopaminergic medication but not ON STN-DBS

    D. Kübler, H. Schroll, A. Kühn (Berlin, Germany)

    Objective: The aim of our study is to obtain a better understanding of how DA and STN-DBS modulate basal ganglia (BG) pathway functions. Background: Patients…
  • 2017 International Congress

    Dopamine agonist therapy mediates relationship between psychomotor inhibition and behavioral impulsivity in Parkinson’s disease.

    T. Turner, J. Renfroe, V. Hinson (Charleston, SC, USA)

    Objective: Evaluate relationship between psychomotor inhibition and behavioral impulsivity in Parkinson’s disease (PD). Background: Impulse control disorders can be challenging iatrogenic effects of dopamine agonist…
  • 2016 International Congress

    Functional deficits during response inhibition improve after dopaminergic medication for Parkinson

    C. Vriend, J.P. Trujillo, N.J.H.M. Gerrits, H.W. Berendse, Y.D. van der Werf, O.A. van den Heuvel (Amsterdam, Netherlands)

    Objective: To study the neural correlates of impulse control in Parkinson's disease (PD) patients before and after the start of dopamine replacement therapy (follow up…
  • « Previous Page
  • 1
  • 2

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An atypical and interesting feature of Parkinson´s disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • #23812 (not found)
  • Approaching Health Care Shaped by Generational Expectations (The AGE Study): Generational Perspective Related to Time
  • Application of the “5-2-1” Screening Criteria in Advanced Parkinson’s Disease Patients Treated with Levodopa-Carbidopa Intestinal Gel: Interim Analysis from the DUOGLOBE Study
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • DaTscan in clinical evaluation of Multiple System Atrophy
  • Decision-making process for opicapone’s bedtime regimen
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley